Revenue | ₹1.07Cr |
Net Profits | ₹0.32Cr |
Net Profit Margins | 29.91% |
Shree Ganesh Biotech India Ltd’s revenue fell -92.73% since last year same period to ₹1.07Cr in the Q3 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated -9.32% fall in its revenue since last 3-months.
Shree Ganesh Biotech India Ltd’s net profit fell -58.44% since last year same period to ₹0.32Cr in the Q3 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated 3100% jump in its net profits since last 3-months.
Shree Ganesh Biotech India Ltd’s net profit margin jumped 471.72% since last year same period to 29.91% in the Q3 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated 3428.97% jumped in its net profit margins since last 3-months.
The revenue for Shree Ganesh Biotech India Ltd in the Q3 results 2025 was ₹1.07Cr.
The net profit for Shree Ganesh Biotech India Ltd in the Q3 results 2025 was ₹0.32Cr.
The net profit margin for Shree Ganesh Biotech India Ltd in the Q3 results 2025 was 29.91%.
The revenue for Shree Ganesh Biotech India Ltd in the Q3 results 2024 was ₹14.72Cr.
The net profit for Shree Ganesh Biotech India Ltd in the Q3 results 2024 was ₹0.77Cr.
The net profit margin for Shree Ganesh Biotech India Ltd in the Q3 results 2024 was 5.23%.